Evidence map›Paper›PMID 39294792›Full record

ArticleBMC research notes2024

Distribution of ABO and D antigen expression in Yogyakarta, Java Island: a pioneer large-scale study in Indonesia.

Hasna Fadlilatul Bidayah, Teguh Triyono, Yann Fichou, Rarastoeti Pratiwi, Diah Nurpratami, Abdul Salam Sofro

Abstract read
In one paragraph

Article in BMC research notes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hasna Fadlilatul BidayahBiotechnology Study Program, Graduate School, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Teguh TriyonoDepartment of Clinical Pathology and Laboratory Medicine, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia. teguhpk@ugm.ac.id.
Yann FichouUniv Brest, Inserm, EFS, UMR1078, GGB, Brest, France.
Rarastoeti PratiwiBiotechnology Study Program, Graduate School, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Diah NurpratamiPoliteknik Kesehatan Bhakti Setya, Yogyakarta, Indonesia.
Abdul Salam SofroBiotechnology Study Program, Graduate School, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Funding

Kementrian Riset Teknologi dan Pendidikan Tinggi, Republik Indonesia 098/E5/PG.02.00.PL/2023;2454/UN1/DITLIT/DitLit/PT.01.03/2023
6 · The paper itself

Abstract

objectiveHere, we sought to report ABO and D antigen distribution in blood donors from Yogyakarta, Java Island, Indonesia. Phenotype data (ABO/D) from donors who donated blood between January 1, 2018, and December 31, 2023, at the Yogyakarta Blood Donor Unit were extracted from the blood donor registry, and phenotype frequency was calculated subsequently.

resultsIn the 245,307 blood donors collected over six years, ABO phenotype frequency: O (frequency: 38.5%) > B (29.4%) > A (24.1%) > AB (8.0%). The D-positive phenotype was far more common (99.5%) than the D-negative phenotype (0.5%). The phenotypic pattern globally is similar to previous reports in Southeast Asia. The D antigen distribution is similar to world distribution as the most common blood group. For the first time in Indonesia, this distribution of ABO and D phenotype is reported in a large-scale study. This work is a pioneer in the coordinated optimization of transfusion guidelines at the national level.

Indexed as

ABO Blood-Group SystemBlood DonorsRh-Hr Blood-Group SystemAdultFemaleHumansIndonesiaMalePhenotypeABO Blood-Group SystemRh-Hr Blood-Group SystemABOBlood Group SystemDistributionIndonesiaRh

Identifiers

PMID39294792
PMCPMC11409473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.